<DOC>
	<DOCNO>NCT01515475</DOCNO>
	<brief_summary>The purpose study compare visual acuity outcomes development strabismus 3-year follow-up period child age 12 &lt; 72 month moderate hyperopia ( spherical equivalent +3.00D +6.00D ) prescribe glass either immediately confirmation pre-specified deterioration criterion .</brief_summary>
	<brief_title>Hyperopia Treatment Study 1 ( HTS1 ) - Glasses vs Observation</brief_title>
	<detailed_description>Moderate high hyperopia associate development strabismus amblyopia . The primary aim treatment asymptomatic moderate high hyperopia preschool child facilitate development normal visual acuity prevent development esotropia amblyopia . Treatment consist optical correction , typically use glass . For child high hyperopia ( &gt; +5.00D ) without strabismus amblyopia , general consensus correction prescribe . Nevertheless , child moderate hyperopia ( +3.00D +5.00D ) without strabismus amblyopia , less consensus among pediatric eye care professional . A survey Lyons et al find 2-year-old child hyperopia great +3.00D , 65 % optometrist would prescribe glass compare 25 % ophthalmologist ; 4-year old hyperopia great +3.00D , 67 % optometrist would prescribe compare 42 % ophthalmologist . The American Association Pediatric Ophthalmology Strabismus ( AAPOS ) recommend correct +4.00D 2 7 year old American Academy Ophthalmology recommend threshold +4.50D correction 2-to 3-year old . Unlike ophthalmology , optometry provide specific recommendation base age level refractive error . Such variation practice highlight lack rigorously collect scientific evidence management condition . Across level hyperopia , ophthalmologists optometrist usually prescribe less full cycloplegic refraction ( 71 % Lyons survey ) strabismus amblyopia present . The rationale proactively correct moderate hyperopia asymptomatic child prevention esotropia , amblyopia , asthenopia . The argument correct moderate hyperopia asymptomatic child expense inconvenience glass might unnecessary potential disruption emmetropization infant toddler . At present , remain uncertain whether correction moderate hyperopia beneficial term visual acuity outcome strabismus development . There evidence use partial correction hyperopia allow emmetropization take place . If refractive correction moderate hyperopia reduce incidence amblyopia and/or esotropia compare refractive correction , glass avoid . However , correct moderate hyperopia reduce development amblyopia and/or esotropia , benefit preemptive refractive correction identify .</detailed_description>
	<mesh_term>Hyperopia</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>1 . Age 12 &lt; 72 month 2 . Refractive error +3.00D +6.00D SE ( cycloplegic refraction ) either eye 3 . Astigmatism &lt; 1.50D eye 4 . Spherical equivalent anisometropia ≤ +1.50D 5 . For child 36 &lt; 72 month age : 1 . No evidence subnormal visual acuity Uncorrected monocular visual acuity eye 20/50 good age 36 &lt; 48 months,20/40 good age 48 &lt; 60 month , 20/32 good age 60 &lt; 72 month measure without cycloplegia use ATSHOTV© visual acuity test protocol 2 . Zero ( 0 ) 1 logMAR line interocular difference ( IOD ) uncorrected visual acuity measure without cycloplegia use ATSHOTV© visual acuity test protocol 3 . Agenormal stereoacuity Randot Preschool Stereotest ( see Table 2 protocol ) 6 . Gestational age &gt; 32 week 7 . Investigator willing prescribe glass per protocol observe hyperopia untreated 3 year unless specific criterion deterioration outline section 3.3.3 confirm . 8 . Parent understand protocol willing accept randomization either glass glass initially , willing wear glass prescribe accept glass prescribe investigator unless specific deterioration criterion outline section 3.3.3 confirm . 9 . Parent phone ( access phone ) willing contact Jaeb Center staff . 10 . Relocation outside area active PEDIG site study within next 36 month anticipate . A patient exclude follow reason : 1 . Any measurable heterotropia distance ( 3 meter ) near ( 1/3 meter ) cover/uncover test . Note patient heterophoria eligible . 2 . Previous document strabismus ( parental report must confirm investigator ) 3 . Manifest latent nystagmus evident clinically 4 . Previous treatment refractive error glass contact unless duration glass contact wear one week le occur 2 month prior enrollment . 5 . Previous intraocular , refractive , extraocular muscle surgery 6 . Previous amblyopia treatment 7 . Previous vergence/accommodative therapy 8 . Parental concern learn development 9 . Ocular comorbidity may reduce visual acuity 10 . Symptoms blur asthenopia 11 . Developmental delay diagnose pediatrician Individualized Education Program ( IEP ) 12 . Known neurological anomaly ( e.g . cerebral palsy , Down syndrome ) 13 . Inability perform visual acuity ATSHOTV test ≥ 36 month age</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>71 Months</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hyperopia</keyword>
	<keyword>Glasses</keyword>
</DOC>